Targeted therapy triggers complex mechanism of resistance
Washington, DC – In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling "network" makes a cancer cell resistant to a drug and selectively target them as well, say researchers at Georgetown Lombardi Comprehensive Cancer Center and Fox Chase Cancer Center. In the September 21 issue of Science Signaling, the investigators discuss how cancer cells activate a network of pro-growth proteins that can bypass a molecule being therapeutically targeted. The researchers specifically found that many ...
Read the release

